Directori de persones
Jose Manuel Valdivielso Revilla

Jose Manuel Valdivielso Revilla

Grau: Doctor/a

973 702 952
valdivielso(ELIMINAR)@irblleida.cat

ResearcherID: http://www.researcherid.com/rid/B-5673-2009

Publicacions

  • Calleros-Basilio, L; Cortes, MA; Garcia-Jerez, A; Luengo-Rodriguez, A; Orozco-Agudo, A; Valdivielso, JM; Rodriguez-Puyol, D; Rodriguez-Puyol, M

    Quality Assurance of Samples and Processes in the Spanish Renal Research Network (REDinREN) Biobank

    Biopreservation and biobanking 14 499-510. .

    [doi:10.1089/bio.2015.0095]

  • Torremade, N; Bozic, M; Panizo, S; Barrio-Vazquez, S; Fernandez-Martin, JL; Encinas, M; Goltzman, D; Arcidiacono, MV; Fernandez, E; Valdivielso, JM

    Vascular Calcification Induced by Chronic Kidney Disease Is Mediated by an Increase of 1 alpha-Hydroxylase Expression in Vascular Smooth Muscle Cells

    JOURNAL OF BONE AND MINERAL RESEARCH 31 1865-1876. .

    [doi:10.1002/jbmr.2852]

  • Bozic, M; Guzman, C; Benet, M; Sanchez-Campos, S; Garcia-Monzon, C; Gari, E; Gatius, S; Valdivielso, JM; Jover, R

    Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis

    JOURNAL OF HEPATOLOGY 65 748-757. .

    [doi:10.1016/j.jhep.2016.05.031]

  • Anguiano, L.; Riera, M.; Pascual, J.; Valdivielso, J.M.; Barrios, C.; Betriu, A.; Clotet, S.; Mojal, S.; Fernández, E.; Soler, M.J.

    Circulating angiotensin converting enzyme 2 activity as a biomarker of silent atherosclerosis in patients with chronic kidney disease

    Atherosclerosis 253 135-143. .

    [doi:10.1016/j.atherosclerosis.2016.08.032]

  • Gracia, M; Betriu, A; Martinez, M; Arroyo, D; Abajo, M; Fernandez, E; Valdivielso, JM

    KLOTHO GENE POLYMORPHISMS ARE ASSOCIATED WITH PROGRESSION OF ATHEROMATOSIS IN PATIENTS WITH CKD. RESULTS OF TWO YEARS FOLLOW-UP OF THE NEFRONA COHORT

    Atherosclerosis 252 17-17. .

    [doi:10.1016/j.atherosclerosis.2016.07.284]

  • Betriu À; Farràs C; Abajo, M; Martinez-Alonso, M; Arroyo, D; Barbe, F; Buti, M; Lecube, A; Portero, M; Purroy, F; Torres, G; Valdivielso, JM; Fernandez, E

    Randomised intervention study to assess the prevalence of subclinical vascular disease and hidden kidney disease and its impact on morbidity and mortality: The ILERVAS project

    Nefrologia 36 389-396. .

    [doi:10.1016/j.nefro.2016.02.008]

  • Valdivielso, J; Martinez-Alonso, M; Betriu, A; Gracia, M; Arroyo, D; Abajo, M; Salgueira, M; Gorriz, JL; Fernandez, E

    THE NUMBER OF ARTERIAL TERRITORIES WITH ATHEROMA PLAQUE PREDICTS THE TIME FREE FROM CARDIOVASCULAR EVENTS IN CHRONIC KIDNEY DISEASE. ANALYSIS OF THE NEFRONA STUDY AFTER 36 MONTHS OF FOLLOW-UP

    NEPHROLOGY DIALYSIS TRANSPLANTATION 31 1429-1429. .

  • Fernandez-Laso, V; Sastre, C; Valdivielso, JM; Betriu, A; Fernandez, E; Egido, J; Martin-Ventura, JL; Blanco-Colio, LM

    Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD

    Clinical Journal Of The American Society Of Nephrology 11 413-422. .

    [doi:10.2215/CJN.07900715]

  • Gracia M; Betriu À; Martínez-Alonso M; Arroyo D; Abajo M; Fernández E; Valdivielso JM

    Predictors of Subclinical Atheromatosis Progression over 2 Years in Patients with Different Stages of CKD

    Clinical Journal Of The American Society Of Nephrology 11 287-296. .

    [doi:10.2215/CJN.01240215]

  • Marco Mayayo MP; Martinez Alonso M; Valdivielso Revilla JM; Fernandez-Giraldez, E

    A New Gender-Specific Formula to Estimate 24-Hour Urine Protein from Protein to Creatinine Ratio

    Nephron 133 232-238. .

    [doi:10.1159/000447604]

  • Jover, R; Bozic, M; Guzman, C; Sanchez-Campos, S; Garcia-Monzon, C; Valdivielso, JM

    VITAMIN D RECEPTOR IS UP-REGULATED IN NAFLD HEPATOCYTES AND IS REQUIRED FOR HIGH FAT DIET-INDUCED STEATOSIS IN APOE(-/-) MICE LIVER

    JOURNAL OF HEPATOLOGY 64 682-682. .

    [doi:10.1016/S0168-8278(16)01294-0]

  • Barrios C; Pascual J; Otero S; Soler MJ; Rodríguez E; Collado S; Faura A; Mojal S; Navarro-González JF; Betriu A; Fernandez E; Valdivielso JM; investigators of the NEFRONA study

    Diabetic nephropathy is an independent factor associated to severe subclinical atheromatous disease

    Atherosclerosis 242 37-44. .

    [doi:10.1016/j.atherosclerosis.2015.06.048]

Projectes

  • Estancias de personal docente y/o investigador senior en centros extranjeros 2022
  • El primer Estudio de asociación de genoma completo (GWAS) con enfermedad coronaria poblacional a 10 años en más de 100.000 participantes para personalizar la prevención cardiovascular en España
  • Influence of SARS-COV-2 infection in atherosclerosis development. “El BUS DE LA SALUT” study
  • SPAIN CKD CAUSE (SPACKDC)
  • INVESTIGO 2022: Grup de recerca translacional vascular i renal
  • Papel de PTEN en la reabsorcion tubular renal de proteinas. Implicaciones en nefropatias proteinuricas
  • Preservació la membrana peritoneal abordant noves vies per inhibir la transició mesotelio-mesenquimal.
  • Acciones de Dinamización "Europa Investigación 2020"
  • Contratos Sara Borrell
  • Papel de la vía PI3K/AKT/mTOR en la regulación de las alteraciones del metabolismo mineral en la enfermedad renal crónica. Implicaciones en la regulación de la síntesis de FGF23.
  • Ajuts destinats a contractar personal investigador novell (FI)
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA CIENTIFICA BASICA PER A LA CARACTERITZACIO D'UN PERFIL LIPIDOMICO Y LIPIDICO DE RIESGO ATEROGENERICO Y DE MORBIMORTALIDAD CARDIOVASCUAL EN LA ENFERMEDAD RENAL CRONICA (ESTADIOS 3 A 5), ESTUDIO PROSPECTIVO NEFRONA.